FOLLICULAR LYMPHOMA REFRACTORY

FOLLICULAR LYMPHOMA REFRACTORY was reported 65 times

FOLLICULAR LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 7 0.0017
1 Non-Standardized Insect Allergenic Extract [EPC] 1 0.0002
2 CD20-directed Cytolytic Antibody [EPC] 51 0.0002
3 Standardized Insect Venom Allergenic Extract [EPC] 1 0.0001
4 Alkylating Drug [EPC] 27 0.0001
5 beta3-Adrenergic Agonist [EPC] 5 0.0001
6 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
7 Topoisomerase Inhibitor [EPC] 7 0.0001
8 Methylxanthine [EPC] 5 0.0001
9 Central Nervous System Stimulant [EPC] 5 0.0001
10 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
12 Leukotriene Receptor Antagonist [EPC] 1 0.0000
13 Provitamin D2 Compound [EPC] 1 0.0000
14 Phenothiazine [EPC] 1 0.0000
15 Platinum-based Drug [EPC] 7 0.0000
16 Thalidomide Analog [EPC] 11 0.0000
17 Corticosteroid [EPC] 27 0.0000
18 Copper-containing Intrauterine Device [EPC] 1 0.0000
19 Non-Standardized Chemical Allergen [EPC] 1 0.0000
20 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
21 Catecholamine [EPC] 1 0.0000
22 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
24 Leukocyte Growth Factor [EPC] 1 0.0000
25 Proton Pump Inhibitor [EPC] 4 0.0000
26 Osmotic Laxative [EPC] 1 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
29 Benzodiazepine [EPC] 1 0.0000